BELOTERO references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
Belotero Volume Lidocaine
Belotero Volume Lidocaine is a dermal filler for the restoration of facial volume. It is intended to correct volume loss and lipoatrophy in areas such as the cheeks, chin, and temples.
Belotero Volume Lidocaine is the volumising grade of the BELOTERO range, a hyaluronic acid dermal filler supplied with lidocaine in the syringe. It is placed in the deep layers of the skin to enhance the cheeks, the temples and the chin, or to treat severe nasolabial folds.
Each 1 mL contains sodium hyaluronate 26 mg/ml and lidocaine hydrochloride 3.0 mg/ml in a physiological phosphate buffer at pH 7. The sodium hyaluronate is cross-linked using 1,4-butanediol diglycidyl ether (BDDE). At 26 mg/ml this is the most concentrated grade in the range. Belotero Volume filler is supplied as 2 x 1 mL, a two-syringe pack rather than the single syringe used across most of the range.
Effects last up to 18 months for nasolabial folds and up to 12 months for the cheeks, temples and chin. ALLPARA supplies Belotero Volume Lidocaine to clinics and licensed practitioners with batch-level traceability and documentation available on request. Wholesale pricing is available to registered professional buyers.
Key Benefits of Belotero Volume Lidocaine
- The volumising grade of the range, placed in the deep layers of the skin to enhance the cheeks, temples and chin and to treat severe nasolabial folds
- Sodium hyaluronate 26 mg/ml with lidocaine hydrochloride 3.0 mg/ml, the most concentrated grade in the range
- Cross-linked using 1,4-butanediol diglycidyl ether (BDDE) in a physiological phosphate buffer at pH 7
- Effects last up to 18 months for nasolabial folds and up to 12 months for the cheeks, temples and chin
- Contains lidocaine to reduce the sensation of pain and improve comfort during injection
- Supplied as a 2 x 1 mL pack, a two-syringe unit rather than the single syringe used across most of the range
- CE marked 0123
- Manufactured by Anteis SA in Plan-les-Ouates, Geneva, Switzerland, for Merz Aesthetics GmbH, Frankfurt am Main
- Batch-level traceability on every unit supplied by ALLPARA, with documentation available to professional buyers on request
Indications and Professional Use
Main indications
- Enhancement of the cheeks
- Enhancement of the temples
- Enhancement of the chin
- Treatment of severe nasolabial folds
Professional use
This product is designed to be injected only by authorised healthcare practitioners who have appropriate training and experience and who are qualified or accredited in accordance with national law. It is not for retail sale to consumers and not for self-application. Injection technique, plane, quantity and patient selection are determined by the treating practitioner, and the injection depth is specific to this grade and must not be inherited from another grade in the range.
Treatment areas
- Cheeks
- Chin
- Temples
- Areas affected by facial volume loss
Patient profile
Suitable for adult patients assessed as appropriate by the treating practitioner. The product is contraindicated in cases of known hypersensitivity to any of its components, especially sodium hyaluronate, lidocaine hydrochloride, BDDE or other amide-type local anaesthetics; in pregnant and breast-feeding women; in patients under 18 years old; in patients presenting a general infection; and in patients presenting an active auto-immune disease. It must not be injected into blood vessels, into areas presenting cutaneous inflammation or infection of immunological, allergic, bacterial, fungal or viral origin, into an area previously treated with a permanent dermal filler, or into the glabellar or nose region. It must not be used in association with other aesthetic techniques such as peeling, dermabrasion or laser treatment before complete healing of the last treatment, and in no case earlier than two weeks after it. Particular care applies to patients taking anticoagulant, antiplatelet, thrombolytic or anti-inflammatory medication, and to patients pre-disposed to hypertrophic scars or keloids. Patient selection and suitability are determined by the practitioner at consultation.
How Belotero Volume Lidocaine Works
Belotero Volume Lidocaine works through sodium hyaluronate at 26 mg/ml, cross-linked using 1,4-butanediol diglycidyl ether (BDDE), with lidocaine hydrochloride 3.0 mg/ml in a physiological phosphate buffer at pH 7. As the volumising grade it acts as an injectable biodegradable implant placed in the deep layers of the skin, which is why it is directed at the cheeks, temples and chin and at severe nasolabial folds rather than at fine lines.
The lidocaine is included to reduce the sensation of pain and improve comfort during injection, and does not alter that mechanism.
Why Order From Allpara
Allpara offers genuine, verified BELOTERO products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
Which BELOTERO grade is Belotero Volume Lidocaine?
Belotero Volume Lidocaine is the volumising grade, supplied at 26 mg/ml sodium hyaluronate with lidocaine hydrochloride 3.0 mg/ml, cross-linked using 1,4-butanediol diglycidyl ether (BDDE). At 26 mg/ml it is the most concentrated grade in the range and is placed in the deep layers of the skin. Grades are not interchangeable.
Which treatment areas is Belotero Volume Lidocaine used for?
It is placed in the deep layers of the skin to enhance the cheeks, the temples and the chin, or to treat severe nasolabial folds. Area selection and placement depth are the treating practitioner's decisions.
How long do the effects of Belotero Volume Lidocaine last?
Effects last up to 18 months for nasolabial folds and up to 12 months for the cheeks, temples and chin. Duration varies with the patient, the area treated, the volume placed and the injection technique.
More from Merz
RADIESSE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
RADIESSE Products
View all 2Clinic alternatives
Pick up where you left off
Belotero Volume Lidocaine
Belotero Volume Lidocaine is the volumising grade of the BELOTERO range, a hyaluronic acid dermal filler supplied with lidocaine in the syringe. It is placed in the deep layers of the skin to enhance the cheeks, the temples and the chin, or to treat severe nasolabial folds.
Each 1 mL contains sodium hyaluronate 26 mg/ml and lidocaine hydrochloride 3.0 mg/ml in a physiological phosphate buffer at pH 7. The sodium hyaluronate is cross-linked using 1,4-butanediol diglycidyl ether (BDDE). At 26 mg/ml this is the most concentrated grade in the range. Belotero Volume filler is supplied as 2 x 1 mL, a two-syringe pack rather than the single syringe used across most of the range.
Effects last up to 18 months for nasolabial folds and up to 12 months for the cheeks, temples and chin. ALLPARA supplies Belotero Volume Lidocaine to clinics and licensed practitioners with batch-level traceability and documentation available on request. Wholesale pricing is available to registered professional buyers.
Key Benefits of Belotero Volume Lidocaine
- The volumising grade of the range, placed in the deep layers of the skin to enhance the cheeks, temples and chin and to treat severe nasolabial folds
- Sodium hyaluronate 26 mg/ml with lidocaine hydrochloride 3.0 mg/ml, the most concentrated grade in the range
- Cross-linked using 1,4-butanediol diglycidyl ether (BDDE) in a physiological phosphate buffer at pH 7
- Effects last up to 18 months for nasolabial folds and up to 12 months for the cheeks, temples and chin
- Contains lidocaine to reduce the sensation of pain and improve comfort during injection
- Supplied as a 2 x 1 mL pack, a two-syringe unit rather than the single syringe used across most of the range
- CE marked 0123
- Manufactured by Anteis SA in Plan-les-Ouates, Geneva, Switzerland, for Merz Aesthetics GmbH, Frankfurt am Main
- Batch-level traceability on every unit supplied by ALLPARA, with documentation available to professional buyers on request
Indications and Professional Use
Main indications
- Enhancement of the cheeks
- Enhancement of the temples
- Enhancement of the chin
- Treatment of severe nasolabial folds
Professional use
This product is designed to be injected only by authorised healthcare practitioners who have appropriate training and experience and who are qualified or accredited in accordance with national law. It is not for retail sale to consumers and not for self-application. Injection technique, plane, quantity and patient selection are determined by the treating practitioner, and the injection depth is specific to this grade and must not be inherited from another grade in the range.
Treatment areas
- Cheeks
- Chin
- Temples
- Areas affected by facial volume loss
Patient profile
Suitable for adult patients assessed as appropriate by the treating practitioner. The product is contraindicated in cases of known hypersensitivity to any of its components, especially sodium hyaluronate, lidocaine hydrochloride, BDDE or other amide-type local anaesthetics; in pregnant and breast-feeding women; in patients under 18 years old; in patients presenting a general infection; and in patients presenting an active auto-immune disease. It must not be injected into blood vessels, into areas presenting cutaneous inflammation or infection of immunological, allergic, bacterial, fungal or viral origin, into an area previously treated with a permanent dermal filler, or into the glabellar or nose region. It must not be used in association with other aesthetic techniques such as peeling, dermabrasion or laser treatment before complete healing of the last treatment, and in no case earlier than two weeks after it. Particular care applies to patients taking anticoagulant, antiplatelet, thrombolytic or anti-inflammatory medication, and to patients pre-disposed to hypertrophic scars or keloids. Patient selection and suitability are determined by the practitioner at consultation.
How Belotero Volume Lidocaine Works
Belotero Volume Lidocaine works through sodium hyaluronate at 26 mg/ml, cross-linked using 1,4-butanediol diglycidyl ether (BDDE), with lidocaine hydrochloride 3.0 mg/ml in a physiological phosphate buffer at pH 7. As the volumising grade it acts as an injectable biodegradable implant placed in the deep layers of the skin, which is why it is directed at the cheeks, temples and chin and at severe nasolabial folds rather than at fine lines.
The lidocaine is included to reduce the sensation of pain and improve comfort during injection, and does not alter that mechanism.
Why Order From Allpara
Allpara offers genuine, verified BELOTERO products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
Which BELOTERO grade is Belotero Volume Lidocaine?
Belotero Volume Lidocaine is the volumising grade, supplied at 26 mg/ml sodium hyaluronate with lidocaine hydrochloride 3.0 mg/ml, cross-linked using 1,4-butanediol diglycidyl ether (BDDE). At 26 mg/ml it is the most concentrated grade in the range and is placed in the deep layers of the skin. Grades are not interchangeable.
Which treatment areas is Belotero Volume Lidocaine used for?
It is placed in the deep layers of the skin to enhance the cheeks, the temples and the chin, or to treat severe nasolabial folds. Area selection and placement depth are the treating practitioner's decisions.
How long do the effects of Belotero Volume Lidocaine last?
Effects last up to 18 months for nasolabial folds and up to 12 months for the cheeks, temples and chin. Duration varies with the patient, the area treated, the volume placed and the injection technique.